Blood arsenic levels and the risk of familial breast cancer in Poland
- PMID: 31348523
- PMCID: PMC7154768
- DOI: 10.1002/ijc.32595
Blood arsenic levels and the risk of familial breast cancer in Poland
Abstract
Arsenic is recognized as a potent carcinogen at high concentrations, but the relationship between environmental arsenic and breast cancer risk has not well been studied. Most research has focused on the effect of arsenic in populations with high endemic exposure, and not in populations with arsenic levels within normal limits. We sought to determine if blood arsenic levels predict the risk of breast and other cancers risk among women in northern Poland. The cohort consisted of 1,702 healthy women, aged 40 and above, identified between 2010 and 2017. Blood arsenic level was determined by inductively coupled plasma mass spectrometry. After an average of 4.5 years of follow-up (range 0.7-7.3 years), there were 110 incident cases of cancer diagnosed in the cohort, including 68 cases of breast cancer. Women in the highest quartile of arsenic had a highly significant 13-fold increased risk of developing breast cancer, compared to women in the lowest quartile (hazard ratio [HR] = 13.2; 95% confidence interval [CI] 4.02-43.0). Results were similar for arsenic and all incident cancers (HR quartile 4 vs. quartile 1 = 13.3; 95% CI 4.78-37.0). If confirmed, our study suggests that the blood arsenic level may be a useful predictive marker of cancer risk in women.
Keywords: Poland; arsenic; blood; cancer; cancer risk; cohort study; familial breast cancer; prospective study.
© 2019 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Figures
Similar articles
-
Serum selenium levels predict survival after breast cancer.Breast Cancer Res Treat. 2018 Jan;167(2):591-598. doi: 10.1007/s10549-017-4525-9. Epub 2017 Oct 17. Breast Cancer Res Treat. 2018. PMID: 29043463
-
Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.Arch Intern Med. 2007 Sep 24;167(17):1837-44. doi: 10.1001/archinte.167.17.1837. Arch Intern Med. 2007. PMID: 17893304
-
Genetic polymorphisms of PPAR gamma, arsenic methylation capacity and breast cancer risk in Mexican women.Salud Publica Mex. 2016 Apr;58(2):220-7. doi: 10.21149/spm.v58i2.7791. Salud Publica Mex. 2016. PMID: 27557380
-
Arsenic Exposure and Breast Cancer Risk: A Re-Evaluation of the Literature.Nutrients. 2020 Oct 28;12(11):3305. doi: 10.3390/nu12113305. Nutrients. 2020. PMID: 33126678 Free PMC article. Review.
-
The possible role of arsenic and gene-arsenic interactions in susceptibility to breast cancer: a systematic review.Rev Environ Health. 2020 Dec 25;36(4):523-534. doi: 10.1515/reveh-2020-0080. Print 2021 Dec 20. Rev Environ Health. 2020. PMID: 34223716 Free PMC article. Review.
Cited by
-
The carcinogenic capacity of arsenic in normal epithelial breast cells and double-positive breast cancer cells.Med Pharm Rep. 2024 Apr;97(2):184-195. doi: 10.15386/mpr-2682. Epub 2024 Apr 25. Med Pharm Rep. 2024. PMID: 38746032 Free PMC article.
-
Modification Effects of Homologous Recombination Repair Gene Polymorphisms on the Associations Between Urinary Metals and Breast Cancer Risk.Biol Trace Elem Res. 2024 May 8. doi: 10.1007/s12011-024-04215-3. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38720017
-
Relationship Between Arsenic in Biological Media and Breast Cancer: A Systematic Review and Meta-Analysis.Biol Trace Elem Res. 2024 Apr 15. doi: 10.1007/s12011-024-04157-w. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38619678 Review.
-
Arsenic and Benzo[a]pyrene Co-exposure Effects on MDA-MB-231 Cell Viability and Migration.Biol Trace Elem Res. 2024 Apr 11. doi: 10.1007/s12011-024-04170-z. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38602648
-
Update of the risk assessment of inorganic arsenic in food.EFSA J. 2024 Jan 18;22(1):e8488. doi: 10.2903/j.efsa.2024.8488. eCollection 2024 Jan. EFSA J. 2024. PMID: 38239496 Free PMC article.
References
-
- Nielsen FC, van Overeem Hansen T, Sorensen CS. Hereditary breast and ovarian cancer: new genes in confined pathways. Nat Rev Cancer 2016;16:599–612. - PubMed
-
- Cuzick J. Preventive therapy for cancer. Lancet Oncol 2017;18:e472–e82. - PubMed
-
- Jenab M, Slimani N, Bictash M, et al. Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum Genet 2009;125:507–25. - PubMed
-
- International Agency for Research on Cancer . Arsenic metals, fibres, and dusts. A review of human carcinogens. 2012;100.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical